This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Typically the initial stage of treatment for substance use, focusing on medically supervised management of withdrawal symptoms
Recovery.com has connected directly with this treatment provider to validate the information in their profile.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Typically the initial stage of treatment for substance use, focusing on medically supervised management of withdrawal symptoms
Please contact the Gosnold Admissions team to hear about your benefits coverage and any out of pocket costs.
Gosnold Treatment Center is a 50-bed detox facility offering medically monitored withdrawal treatment for substance use disorders. Patient stays are typically 4-8 days, and use a variety of medications to treat withdrawal, minimize discomfort, and avert complications. Care is managed by a team of physicians, nurses, counselors, case managers and recovery aides.
Programming includes educational sessions each morning, both individual and group counseling, and onsite 12-Step recovery support meetings each evening.
Other Gosnold locations offer step-down programs like residential, partial hospitalization (PHP), and intensive outpatient (IOP) treatment, as well as sober living facilities.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
The Joint Commission accreditation is a voluntary, objective process that evaluates and accredits healthcare organizations (like treatment centers) based on performance standards designed to improve quality and safety for patients. To be accredited means the treatment center has been found to meet the Commission's standards for quality and safety in patient care.
Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT
Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.
Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.